An Efficacy and Safety Study of 3 Fixed Doses of JNJ-37822681 in Participants With Schizophrenia
Clinical trial NCT00728195 · COMPLETED
Trial details
- NCT number
- NCT00728195
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2010-02-01
- Enrollment
- 498
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.